Evidence map›Paper›PMID 28658137›Full record

Observational studyMedicine2017

Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohorts.

Benjamín Fernández-Gutiérrez, Pedro P Perrotti, Javier P Gisbert, Eugeni Domènech, Antonio Fernández-Nebro, Juan D Cañete, Carlos Ferrándiz, Jesús Tornero, Valle García-Sánchez, Julián Panés and 8 more

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Understanding the therapeutic toolkit for inflammatory bowel disease.Nature reviews. Gastroenterology & hepatology · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. The role of B cells in atherosclerosis.Nature reviews. Cardiology · 2019
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 14 institutions in 3 countries.

Benjamín Fernández-GutiérrezRheumatology Department and Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Clínico San Carlos, Madrid Rheumatology Research Group, Vall d'Hebron Hospital Research Institute Department of Medicine, University of Barcelona, Barcelona Gastroenterology Department, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD) Gastroenterology and Hepatology Department, Hospital Universitari Germans Trias i Pujol, Badalona UGC Reumatología, Instituto de Investigación Biomédica de Málaga, Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga Rheumatology Department, Hospital Clinic and IDIBAPS Dermatology Department, Hospital Universitari Germans Trias i Pujol, Badalona Universidad Autónoma de Barcelona, Barcelona Rheumatology Department, Hospital General Universitario de Guadalajara, Guadalajara Hospital Universitario Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba, Córdoba Hospital Clínic de Barcelona and IDIBAPS, Barcelona Dermatology Department Rheumatology Department, Complejo Hospitalario Universitario A Coruña, INIBIC, A Coruña Rheumatology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat Rheumatology Department, Hospital Universitario Doce de Octubre, Madrid, Spain.
Pedro P Perrotti
Javier P Gisbert
Eugeni Domènech
Antonio Fernández-Nebro
Juan D Cañete
Carlos Ferrándiz
Jesús Tornero
Valle García-Sánchez
Julián Panés
Eduardo Fonseca
Francisco Blanco
Jesús Rodríguez-Moreno
Patricia Carreira
Antonio Julià
Sara Marsal
Luis Rodriguez-Rodriguez
IMID Consortium
Hebron University · PSUniversitat Autònoma de Barcelona · ESBellvitge University Hospital · ESCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESComplexo Hospitalario Universitario A Coruña · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESHospital Clínic de Barcelona · ESHospital Clínico San Carlos · ESHospital Regional Universitario de Málaga · ESHospital Universitario 12 De Octubre · ESHospital Universitario de Guadalajara · ESHospital Universitario de La Princesa · ESInstituto Maimónides de Investigación Biomédica de Córdoba · ESUniversity Dermatology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To analyze in several immune-mediated inflammatory diseases (IMIDs) the influence of demographic and clinical-related variables on the prevalence of cardiovascular disease (CVD), and compare their standardized prevalences.Cross-sectional study, including consecutive patients diagnosed with rheumatoid arthritis, psoriatic arthritis, psoriasis, systemic lupus erythematosus, Crohn disease, or ulcerative colitis, from rheumatology, gastroenterology, and dermatology tertiary care outpatient clinics located throughout Spain, between 2007 and 2010. Our main outcome was defined as previous diagnosis of angina, myocardial infarction, peripheral vascular disease, and/or stroke. Bivariate and multivariate logistic and mixed-effects logistic regression models were performed for each condition and the overall cohort, respectively. Standardized prevalences (in subjects per 100 patients, with 95% confidence intervals) were calculated using marginal analysis.We included 9951 patients. For each IMID, traditional cardiovascular risk factors had a different contribution to CVD. Overall, older age, longer disease duration, presence of traditional cardiovascular risk factors, and male sex were independently associated with a higher CVD prevalence. After adjusting for demographic and traditional cardiovascular risk factors, systemic lupus erythematosus exhibited the highest CVD standardized prevalence, followed by rheumatoid arthritis, psoriasis, Crohn disease, psoriatic arthritis, and ulcerative colitis (4.5 [95% confidence interval (CI): 2.2, 6.8], 1.3 [95% CI: 0.8, 1.8], 0.9 [95% CI: 0.5, 1.2], 0.8 [95% CI: 0.2, 1.3], 0.6 [95% CI: 0.2, 1.0], and 0.5 [95% CI: 0.1, 0.8], respectively).Systemic lupus erythematosus, rheumatoid arthritis, and psoriasis are associated with higher prevalence of CVD compared with other IMIDs. Specific prevention programs should be established in subjects affected with these conditions to prevent CVD.

Indexed as

AdultAgedCardiovascular DiseasesCohort StudiesCross-Sectional StudiesFemaleHumansImmune System DiseasesInflammationLogistic ModelsMaleMiddle AgedMultivariate AnalysisPrevalenceRisk FactorsSpain

Identifiers

PMID28658137
PMCPMC5500059
OpenAlexW2725043889

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.